Ted Love | President and CEO |
Jeff Farrow | Chief Financial Officer |
David Johnson | Chief Commercial Officer |
Kim Smith-Whitley | EVP and Head of R&D |
Steven Immergut | SVP, Head of Corporate Communications and IR |
Brian Cathers | Chief Scientific Officer |
Gregory Renza | RBC Capital Markets |
Mark Breidenbach | Oppenheimer & Co. Inc. |
Raju Prasad | William Blair |
Alethia Young | Cantor Fitzgerald |
Akash Tewari | Jefferies |
Danielle Brill | Raymond James |
Paul Choi | Goldman Sachs |
Jason Gerberry | Bank of America |
Joon Lee | Truist Securities |
Ritu Baral | Cowen and Company |
Yanan Zhu | Wells Fargo Securities |
Yatin Suneja | Guggenheim Partners |
Tessa Romero | J.P. Morgan |
Benjamin Burnett | Stifel, Nicolaus & Co. Inc. |
Greetings, and welcome to the Global Blood Therapeutics' Fourth Quarter and Full Year 2021 Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the prepared remarks. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Steven Immergut.